This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Wall Street analysts upgraded Moderna Inc and Evolution Petroleum Corp, and raised Enbridge's price target. Check out analysts' views on MRNA stock.
Read original at benzingaStocks · News reference
CIBC analyst Robert Catellier upgrades Enbridge (TSX:ENB) from Neutral to Outperformer and raises the price target from C$77 to C$78.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wall Street analysts upgraded Moderna Inc and Evolution Petroleum Corp, and raised Enbridge's price target. Check out analysts' views on MRNA stock.
Read original at benzingaEnbridge Inc. (Enbridge) (TSX:ENB) (NYSE:ENB) announced today that, through a wholly-owned subsidiary, it has entered into a definitive agreement to acquire Salt Creek Midstream's crude oil gathering business,
Read original at benzingaBarclays analyst Theresa Chen maintains Enbridge (TSX:ENB) with a Equal-Weight and raises the price target from C$73 to C$75.
Read original at benzinga